Invention Grant
- Patent Title: Aminopyrimidinyl derivatives
-
Application No.: US17363494Application Date: 2021-06-30
-
Publication No.: US11655252B2Publication Date: 2023-05-23
- Inventor: Brian Stephen Gerstenberger , Wenhua Jiao , Manjinder Singh Lall , Ricardo Lira , Mark Edward Schnute
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. David Joran
- Main IPC: C07D471/18
- IPC: C07D471/18 ; A61K45/06
Abstract:
A compound of formula I:
or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are each independently hydrogen or hydroxy; wherein R1 and R2 are not both hydroxy. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.
or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are each independently hydrogen or hydroxy; wherein R1 and R2 are not both hydroxy. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.
Public/Granted literature
- US20220002301A1 AMINOPYRIMIDINYL DERIVATIVES Public/Granted day:2022-01-06
Information query
